Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction

Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a comparison between autologous bone marrow-derived mononuclear cells (BMMNC) and mesenchymal stem cells (MSC) on therapeutic efficacy after MI wa...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Spoel, T. I. G., Gathier, W. A., Koudstaal, S., van Slochteren, F., of Lorkeers, S. Jansen, Sluijter, J. P. G., Hoefer, I. E., Steendijk, P., Cramer, M. J. M., Doevendans, P. A., van Belle, E., Chamuleau, S. A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623074/
https://www.ncbi.nlm.nih.gov/pubmed/26382088
http://dx.doi.org/10.1007/s12265-015-9643-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623074/
https://www.ncbi.nlm.nih.gov/pubmed/26382088
http://dx.doi.org/10.1007/s12265-015-9643-3

Ejemplares similares